| Targeting PI3K in cancer: mechanisms and advances in clinical trials J Yang, J Nie, X Ma, Y Wei, Y Peng, X Wei Molecular cancer 18 (1), 26, 2019 | 1205 | 2019 |
| Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials Y Cheng, C He, M Wang, X Ma, F Mo, S Yang, J Han, X Wei Signal transduction and targeted therapy 4 (1), 62, 2019 | 796 | 2019 |
| A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity J Yang, W Wang, Z Chen, S Lu, F Yang, Z Bi, L Bao, F Mo, X Li, Y Huang, ... Nature 586 (7830), 572-577, 2020 | 714 | 2020 |
| Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases Y Cheng, X Ma, Y Wei, XW Wei Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1871 (2), 289-312, 2019 | 257 | 2019 |
| Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis X Yuan, J Zhang, D Li, Y Mao, F Mo, W Du, X Ma Gynecologic oncology 147 (1), 181-187, 2017 | 215 | 2017 |
| The diagnostic role of a short screening tool—the distress thermometer: a meta-analysis X Ma, J Zhang, W Zhong, C Shu, F Wang, J Wen, M Zhou, Y Sang, ... Supportive care in cancer 22, 1741-1755, 2014 | 205 | 2014 |
| Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis Z Zhao, S Li, G Liu, F Yan, X Ma, Z Huang, H Tian PloS one 7 (7), e41641, 2012 | 205 | 2012 |
| The role of myeloid-derived suppressor cells in patients with solid tumors: a meta-analysis S Zhang, X Ma, C Zhu, L Liu, G Wang, X Yuan PloS one 11 (10), e0164514, 2016 | 194 | 2016 |
| Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency Z Li, X Lai, S Fu, L Ren, H Cai, H Zhang, Z Gu, X Ma, K Luo Advanced Science 9 (22), 2201734, 2022 | 178 | 2022 |
| Combination of immunotherapy with targeted therapy: theory and practice in metastatic melanoma C Yu, X Liu, J Yang, M Zhang, H Jin, X Ma, H Shi Frontiers in immunology 10, 431246, 2019 | 116 | 2019 |
| Preparation and application of pH-responsive drug delivery systems H Ding, P Tan, S Fu, X Tian, H Zhang, X Ma, Z Gu, K Luo Journal of Controlled Release 348, 206-238, 2022 | 111 | 2022 |
| Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies YW Zhou, Y Xie, LS Tang, D Pu, YJ Zhu, JY Liu, XL Ma Signal transduction and targeted therapy 6 (1), 317, 2021 | 105 | 2021 |
| Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis B Zhang, F Zhu, X Ma, Y Tian, D Cao, S Luo, Y Xuan, L Liu, Y Wei Radiotherapy and Oncology 112 (2), 250-255, 2014 | 102 | 2014 |
| A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody Z Li, H Cai, Z Li, L Ren, X Ma, H Zhu, Q Gong, H Zhang, Z Gu, K Luo Bioactive materials 21, 299-312, 2023 | 89 | 2023 |
| The role of tumor-stroma interactions in drug resistance within tumor microenvironment Y Ni, X Zhou, J Yang, H Shi, H Li, X Zhao, X Ma Frontiers in Cell and Developmental Biology 9, 637675, 2021 | 87 | 2021 |
| Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? M Deng, X Ma, X Liang, C Zhu, M Wang Oncotarget 8 (23), 37200, 2017 | 86 | 2017 |
| Shear wave elastography for differentiation of benign and malignant thyroid nodules: a meta‐analysis B Zhang, X Ma, N Wu, L Liu, X Liu, J Zhang, J Yang, T Niu Journal of Ultrasound in Medicine 32 (12), 2163-2169, 2013 | 85 | 2013 |
| Radiomics-based machine learning in differentiation between glioblastoma and metastatic brain tumors C Chen, X Ou, J Wang, W Guo, X Ma Frontiers in oncology 9, 806, 2019 | 83 | 2019 |
| Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation S He, T Yin, D Li, X Gao, Y Wan, X Ma, T Ye, F Guo, J Sun, Z Lin, Y Wang Journal of translational medicine 11, 1-11, 2013 | 81 | 2013 |
| Immune checkpoint HLA-E: CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance X Liu, J Song, H Zhang, X Liu, F Zuo, Y Zhao, Y Zhao, X Yin, X Guo, X Wu, ... Cancer Cell 41 (2), 272-287. e9, 2023 | 77 | 2023 |
